Targeting Bcl-2/Bcl-XL Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts
Fariba Némati(Institut Curie), Didier Decaudin(Institut Curie)
Cited by 49
Related Papers
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
|Oncotarget|2018|24